GlassScriptPhysician profile
Ashishkumar R Patel
NPI 1699290775
$12,582.44
in general payments reported to CMS, 2019-2025
13 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,060 · 2021: $52.00 · 2022: $1,003 · 2023: $41.60 · 2024: $35.41 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2019 | |
| Stryker Corporation | $1,033.96 | 2022-2025 | Inspace |
| Mid-Atlantic Surgical Systems, LLC | $1,008.07 | 2020 | |
| Smith+Nephew, INC. | $200.25 | 2020-2025 | Stravix Pl, Pico |
| Treace Medical Concepts, INC. | $121.89 | 2019 | |
| Zimmer Biomet Holdings, INC. | $55.22 | 2019 | |
| Trimed, INC. | $38.72 | 2021 | |
| Endo USA, INC. | $36.79 | 2025 | Xiaflex |
| Acera Surgical, INC. | $22.61 | 2025 | Restrata Wound Matrix |
| Bioventus LLC | $21.96 | 2022 | |
| Ethicon US, LLC | $15.21 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $15.00 | 2024 | Caldolor |
| Orthofix Medical, INC. | $12.76 | 2023 | Spinal-Stim, Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashishkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.